{"id":"W4406810524","doi":"10.1016/j.kint.2024.11.013","title":"Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","year":2025,"lang":"en","type":"article","venue":"Kidney International","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health; University of Pennsylvania; OPKO Health; Vertex Pharmaceuticals; Menarini Group; Korean Society of Nephrology; Ono Pharmaceutical; Fresenius Medical Care North America; Astellas Pharma; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Nierstichting; European Commission; Kissei; Inozyme Pharma; Torii Pharmaceutical; Amicus Therapeutics; Alexion Pharmaceuticals; International Osteoporosis Foundation; American Society of Nephrology; Intas Pharmaceuticals; AstraZeneca; Hong Kong Society of Nephrology; Amgen; Kidney Disease: Improving Global Outcomes","keywords":"Kidney disease; Medicine; Disease; Kidney; Bone disease; Internal medicine; Intensive care medicine; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005228865,0.0003631081,0.0004618576,0.0001247949,0.0002324254,0.0001371419,0.0002213618,0.0000861604,0.000575256],"category_scores_gemma":[0.002940048,0.0003141424,0.0002117858,0.0001379047,0.0002286869,0.0002514576,0.0003380117,0.0001636379,0.00005443222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004332637,"about_ca_system_score_gemma":0.002537003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000950408,"about_ca_topic_score_gemma":0.00007276341,"domain_scores_codex":[0.9981283,0.00003958471,0.0003860952,0.0006072341,0.0004700276,0.0003687413],"domain_scores_gemma":[0.9974622,0.0001313949,0.0001288414,0.0003583745,0.000186461,0.001732785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006189035,0.0004906625,0.7877557,0.00004595588,0.0009104397,0.0001379497,0.00008560657,0.000002947685,0.0005257131,0.01342609,0.1946972,0.001302875],"study_design_scores_gemma":[0.02227091,0.000131342,0.7182941,0.0003971984,0.001053825,0.000007657211,0.0001668844,0.009323651,0.00002695928,0.006064997,0.2417954,0.0004670741],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4699899,0.01994046,0.006167907,0.4260179,0.00456445,0.002434058,0.03995287,0.0005190672,0.03041344],"genre_scores_gemma":[0.9697658,0.0003594748,0.0003127609,0.01678078,0.0002149195,0.00007563711,0.003987188,0.00001861605,0.00848479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4997759,"threshold_uncertainty_score":0.999931,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007703520937452834,"score_gpt":0.2828709671059757,"score_spread":0.2751674461685228,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}